Breaking News
0

Advaxis Inc (ADXS)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Advaxis's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
0.3250 +0.0195    +6.38%
15:59:59 - Closed. Currency in USD ( Disclaimer )
After Hours
0.3221
-0.0029
-0.8923%
17:36:03 - Real-time Data
Type: Equity
Market: United States
ISIN: US0076243072 
CUSIP: 007624307
  • Volume: 11,198,356
  • Bid/Ask: 0.3210 / 0.3283
  • Day's Range: 0.2750 - 0.3378
Advaxis 0.3250 +0.0195 +6.38%

ADXS Overview

 
This is the main Advaxis Inc stock chart and current price. You can find more details by going to one of the sections under this page such as historical data, charts, technical analysis and others.
Loading
Last Update:
  • 1 Day
  • 1 Week
  • 1 Month
  • 3 Months
  • 6 Months
  • 1 Year
  • 5 years
  • Max
Prev. Close0.3055
Day's Range0.275 - 0.3378
Revenue22.02M
Open0.29
52 wk Range0.2051 - 11.625
EPS - 4.31
Volume11,198,356
Market Cap8.03M
Dividend (Yield)N/A (N/A)
Average Vol. (3m)5,086,237
P/E RatioN/A
Beta3.13
1-Year Change - 97.37%
Shares Outstanding24,710,135
Next Earnings DateDec 20, 2019
What is your sentiment on Advaxis?
or
Market is currently closed. Voting is open during market hours.

Advaxis Inc News


Advaxis Inc Analysis


Technical Summary

Type 5 mins 15 mins Hourly Daily Monthly
Moving Averages Buy Buy Buy Strong Sell Strong Sell
Technical Indicators Neutral Strong Buy BUY Sell Strong Sell
Summary Neutral Strong Buy Buy Strong Sell Strong Sell

Candlestick Patterns

 

Filter Table By:

Candle Sticks Characteristics:

Time Frame
Type
Pattern Indication
Reliability
Pattern Timeframe Reliability Candles Ago Candle Time
Emerging Patterns
Bullish Engulfing 1D Current
Completed Patterns
Downside Gap Three Methods 1W 2 Sep 29, 2019
Bullish doji Star 1D 2 Oct 11, 2019
Abandoned Baby Bearish 1D 3 Oct 10, 2019

Advaxis Inc Quotes

Exchange Last Bid Ask Volume Change % Currency Time
  NASDAQ 0.3250 0.3210 0.3283 11,198,356 +6.38% USD 15:59:59  
  Berlin 0.268 0.156 0.410 0 -5.63% EUR 12:42:00  
  Stuttgart 0.248 2.562 2.730 0 0.00% EUR 01:00:00  

Trending Stocks

Create Alert
Add to Portfolio
Add to/Remove from a Portfolio  
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

  Name Last High Low Chg. Chg. % Vol. Time
  Apple 235.32 237.65 234.88 -0.55 -0.23% 21.69M 15:59:59  
  Netflix 284.25 285.87 279.40 -1.28 -0.45% 7.66M 15:59:59  
  Tesla 257.89 260.00 254.12 +0.93 +0.36% 6.43M 15:59:59  
  Alibaba ADR 175.29 176.75 172.69 +4.13 +2.41% 13.72M 15:59:59  
  JPMorgan 119.96 121.59 117.87 +3.51 +3.01% 23.34M 15:59:59  
  Bank of America 29.73 30.24 29.11 +0.59 +2.02% 78.20M 15:59:59  
  Berkshire Hathaway B 209.38 210.15 207.57 +1.47 +0.71% 2.99M 15:59:59  
  Sangamo Therapeutics 8.40 8.45 7.94 +0.37 +4.61% 3.65M 15:59:59  
  IBM 143.00 143.72 141.81 +0.96 +0.68% 3.00M 15:59:59  
  Microsoft 141.58 141.79 139.81 +2.02 +1.45% 19.44M 15:59:59  

Advaxis Inc Company Profile

IndustryBiotechnology & Drugs
SectorHealthcare
Employees

58

Equity Type

ORD

Advaxis, Inc. is a clinical-stage biotechnology company focused on the discovery, development and commercialization of Listeria monocytogenes (Lm)-Listeriolysin O (LLO) cancer immunotherapies. These immunotherapies are based on a platform technology that utilizes live attenuated Lm bioengineered to secrete antigen/adjuvant fusion proteins. These Lm-LLO strains integrate multiple functions into a single immunotherapy as they access and direct antigen presenting cells to stimulate anti-tumor T-cell immunity, stimulate and activate the immune system with the equivalent of multiple adjuvants, and simultaneously reduce tumor protection in the tumor microenvironment to enable the T-cells to eliminate tumors. Axalimogene filolisbac is its lead Lm-LLO immunotherapy product candidate for the treatment of Human Papilloma Virus-associated cancers. ADXS-PSA is its Lm-LLO immunotherapy product candidate that targets the Prostate Specific Antigen (PSA) associated with prostate cancer.

Read More

Start Trading With Top Industry Brokers

Brokers Regulation Minimum Deposit
Securities Investor Protection Corporation (United States) $0 Start Trading
U.S. Commodity Futures Trading Commission (United States), Securities and Exchange Commission (United States) $0 Start Trading
National Futures Association (United States), Financial Industry Regulatory Authority (United States), Securities Investor Protection Corporation (United States) $500 Start Trading
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

ADXS Comments

Write your thoughts about Advaxis Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Max McAuliffe
Max McAuliffe Oct 07, 2019 2:55PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Buy now. Smart investment.
Neil Nedd
Neil Nedd Mar 01, 2019 9:47PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
AVGR is really taking off right now. It's a much better bang for your penny
Thomas Wilson
Thomas Wilson Nov 09, 2018 3:35PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Advaxis is finished, invest in AVGR while its still low.
Quinn Haynie
Quinn Haynie Nov 05, 2018 10:24AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
going to be delisted
Joel Hanson
Joel Hanson Nov 18, 2016 10:50AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
$ADXS has all 4 analyst covering it saying “buy” with an ave 12 month target price of $23.25. That’s 139% ROI at its current price of $9.74.
mehmet ozdemir
mehmet ozdemir Nov 18, 2016 10:50AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
bankrupt soon
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
or
Sign up with Email